US · brain tumor therapy · medical devices · oncology
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series E · Jun 2026 · $100M
Viking Global Investors lead, Gilde Healthcare, MVM Partners, Evidity Health Capital, FemHealth Ventures, Medtech Venture Partners
Reported by Ventureburn · SEC filing: $50M sold under the offering
Missing a round, or an investor who was in one? Tell us.